Natural Beauty Big Leaguer L’Occitane Acquires No. 1 In British Luxury Skin Care
Executive Summary
L’Occitaine’s $900m Elemis buy will build out the manufacturer/retailer’s premium, natural-oriented beauty portfolio, adding a prestige brand that aspires to be a leader in global skin care with its nature/science balance and cross-generational consumer appeal.
You may also be interested in...
US FDA Says White Paper Could Inform Rulemaking For Cosmetic Talc-Asbestos Testing
Formed by the FDA in fall 2018 and convened in early 2020 for a public meeting, the Interagency Working Group on Asbestos in Consumer Products maintains that electron microscopy should be a first-line method for detecting asbestos in cosmetic talc and talc-containing products, and that labs should report elongate mineral particles beyond those classically understood as asbestos.
US FDA Advises Drug Firms To Test For Benzene Contamination As Root-Cause Investigation Continues
The FDA offers insight into possible sources of benzene contamination in drug products, including aerosol spray propellants, carbomers, or other drug components made from hydrocarbons. Manufacturers that find benzene in drug product batches at levels exceeding 2 ppm should not release the product or, if already in distribution, discuss with the FDA initiating a voluntary recall.
Global Beauty And Personal Care Growth Unleashed Despite Market Tensions In Changed World
The Global Wellness Institute outlines trends shaping the post-pandemic beauty and personal-care space, projected to see annual growth in excess of 8% from 2020 through 2025.